Has Shiraz Farooq, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,232 in general payments to Shiraz Farooq, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shiraz Farooq, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shiraz Farooq, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shiraz Farooq, MD

Colon & Rectal Surgery · Tampa, FLNPI 1205970431

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.6% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by THD America, Inc. at 24.9% of the total. That places this record below the midpoint for colon & rectal surgery clinicians in FL, where the typical reported total is $4,865.

$2,232in general payments, 2019–2025

Across 27 payments — averaging $82.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

THD America, Inc.$555
Axonics, Inc.$461
Palette Life Sciences, Inc.$226
Medtronic$166
Johnson & Johnson$141
Genentech USA, Inc.$141
plus $541 from 7 others

$301,506in research payments, 2019–2025

Across 111 payments — averaging $2716.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$205K
Janssen Research & Development, LLC$97K

What the payments were for

Food & beverage$2,08994%
Education$171%
Entertainment$1266%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
THD America, Inc.	3	$555
Axonics, Inc.	5	$461
Palette Life Sciences, Inc.	3	$226
Medtronic	1	$166
Johnson & Johnson	2	$141
Genentech USA, Inc.	1	$141
Bioness Inc	1	$126
Hologic Sales And Service, LLC	2	$125
Medical Device Business Services, Inc.	1	$83
Amgen	1	$75
Redhill Biopharma Inc.	3	$72
Trevena, Inc.	2	$34
Boston Scientific	2	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,232 in reported general payments places this provider in the 30th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$51,952

Medicare patients

Services billed

345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf	14	$2,255
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	11	$79
Pantoprazole Sodium	19	$59
Metronidazole	13	$56

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Tampa

Allen ChudzinskiTampa$252K
Cesar SantiagoTampa$193K
Jaime SanchezTampa$157K
Jorge MarcetTampa$74K
Gavin SigleTampa$15K
Robert BennettTampa$14K
Julian SanchezTampa$12K
Mark SolimanAltamonte Springs$872K
Eduardo Parra DavilaWest Palm Beach$577K
Matthew AlbertAltamonte Springs$514K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →